<!DOCTYPE html>
<html lang="en" dir="auto" data-theme="auto">

<head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>Selam | Tıp Notları</title>
<meta name="keywords" content="">
<meta name="description" content="HbA1c düşüşü
Yaklaşık %1–1.5

Başlangıç ve doz

Genelde 500 mg 1x1 başlanır
Tolere edildikçe artırılır
Maksimum genelde 2.000 mg/gün


Endikasyon

Tip 2 DM
Bazı kılavuzlarda prediabet


Kontrendikasyon

GFR &lt; 30 mL/dk
Ciddi karaciğer yetmezliği
Laktik asidoz riski
">
<meta name="author" content="">
<link rel="canonical" href="http://localhost:1313/endokrin/diyabet/selam/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.f2358486aec7d810363730195464c83b631d177809db0b1735067dca8f036d81.css" integrity="sha256-8jWEhq7H2BA2NzAZVGTIO2MdF3gJ2wsXNQZ9yo8DbYE=" rel="preload stylesheet" as="style">
<link rel="icon" href="http://localhost:1313/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="http://localhost:1313/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="http://localhost:1313/favicon-32x32.png">
<link rel="apple-touch-icon" href="http://localhost:1313/apple-touch-icon.png">
<link rel="mask-icon" href="http://localhost:1313/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" type="text/html" href="http://localhost:1313/endokrin/diyabet/selam/" title="reveal">
<link rel="alternate" hreflang="en" href="http://localhost:1313/endokrin/diyabet/selam/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
                color-scheme: dark;
            }

            .list {
                background: var(--theme);
            }

            .toc {
                background: var(--entry);
            }
        }

        @media (prefers-color-scheme: light) {
            .list::-webkit-scrollbar-thumb {
                border-color: var(--code-bg);
            }
        }

    </style>
</noscript>
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.querySelector("html").dataset.theme = 'dark';
    } else if (localStorage.getItem("pref-theme") === "light") {
       document.querySelector("html").dataset.theme = 'light';
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.querySelector("html").dataset.theme = 'dark';
    } else {
        document.querySelector("html").dataset.theme = 'light';
    }

</script><meta property="og:url" content="http://localhost:1313/endokrin/diyabet/selam/">
  <meta property="og:site_name" content="Tıp Notları">
  <meta property="og:title" content="Selam">
  <meta property="og:description" content="HbA1c düşüşü Yaklaşık %1–1.5
Başlangıç ve doz Genelde 500 mg 1x1 başlanır Tolere edildikçe artırılır Maksimum genelde 2.000 mg/gün Endikasyon Tip 2 DM Bazı kılavuzlarda prediabet Kontrendikasyon GFR &lt; 30 mL/dk Ciddi karaciğer yetmezliği Laktik asidoz riski ">
  <meta property="og:locale" content="tr-tr">
  <meta property="og:type" content="article">
    <meta property="article:section" content="endokrin">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Selam">
<meta name="twitter:description" content="HbA1c düşüşü
Yaklaşık %1–1.5

Başlangıç ve doz

Genelde 500 mg 1x1 başlanır
Tolere edildikçe artırılır
Maksimum genelde 2.000 mg/gün


Endikasyon

Tip 2 DM
Bazı kılavuzlarda prediabet


Kontrendikasyon

GFR &lt; 30 mL/dk
Ciddi karaciğer yetmezliği
Laktik asidoz riski
">


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position":  1 ,
      "name": "Endokrin",
      "item": "http://localhost:1313/endokrin/"
    }, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Oral Antidiyabetikler",
      "item": "http://localhost:1313/endokrin/diyabet/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "Selam",
      "item": "http://localhost:1313/endokrin/diyabet/selam/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "Selam",
  "name": "Selam",
  "description": "HbA1c düşüşü Yaklaşık %1–1.5\nBaşlangıç ve doz Genelde 500 mg 1x1 başlanır Tolere edildikçe artırılır Maksimum genelde 2.000 mg/gün Endikasyon Tip 2 DM Bazı kılavuzlarda prediabet Kontrendikasyon GFR \u0026lt; 30 mL/dk Ciddi karaciğer yetmezliği Laktik asidoz riski ",
  "keywords": [
    
  ],
  "articleBody": "HbA1c düşüşü Yaklaşık %1–1.5\nBaşlangıç ve doz Genelde 500 mg 1x1 başlanır Tolere edildikçe artırılır Maksimum genelde 2.000 mg/gün Endikasyon Tip 2 DM Bazı kılavuzlarda prediabet Kontrendikasyon GFR \u003c 30 mL/dk Ciddi karaciğer yetmezliği Laktik asidoz riski ",
  "wordCount" : "37",
  "inLanguage": "en",
  "datePublished": "0001-01-01T00:00:00Z",
  "dateModified": "0001-01-01T00:00:00Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "http://localhost:1313/endokrin/diyabet/selam/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "Tıp Notları",
    "logo": {
      "@type": "ImageObject",
      "url": "http://localhost:1313/favicon.ico"
    }
  }
}
</script>
</head>
<body id="top">
    <header class="header">
  <nav class="nav">
    

    
      
        
        <a href="/endokrin/diyabet/" class="nav-parent">
          Oral Antidiyabetikler
        </a>
      
    
  </nav>
</header>
<main class="main">

<article class="post-single">
  <header class="post-header">
    <div class="breadcrumbs"><a href="http://localhost:1313/">Home</a>&nbsp;»&nbsp;<a href="http://localhost:1313/endokrin/">Endokrin</a>&nbsp;»&nbsp;<a href="http://localhost:1313/endokrin/diyabet/">Oral Antidiyabetikler</a></div>
    <h1 class="post-title entry-hint-parent">
      Selam
    </h1>
    <div class="post-meta">

</div>
  </header> 
  <div class="post-content"><h1 id="hba1c-düşüşü">HbA1c düşüşü<a hidden class="anchor" aria-hidden="true" href="#hba1c-düşüşü">#</a></h1>
<p>Yaklaşık %1–1.5</p>
<hr>
<h1 id="başlangıç-ve-doz">Başlangıç ve doz<a hidden class="anchor" aria-hidden="true" href="#başlangıç-ve-doz">#</a></h1>
<ul>
<li>Genelde 500 mg 1x1 başlanır</li>
<li>Tolere edildikçe artırılır</li>
<li>Maksimum genelde 2.000 mg/gün</li>
</ul>
<hr>
<h1 id="endikasyon">Endikasyon<a hidden class="anchor" aria-hidden="true" href="#endikasyon">#</a></h1>
<ul>
<li>Tip 2 DM</li>
<li>Bazı kılavuzlarda prediabet</li>
</ul>
<hr>
<h1 id="kontrendikasyon">Kontrendikasyon<a hidden class="anchor" aria-hidden="true" href="#kontrendikasyon">#</a></h1>
<ul>
<li>GFR &lt; 30 mL/dk</li>
<li>Ciddi karaciğer yetmezliği</li>
<li>Laktik asidoz riski</li>
</ul>


  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>

  </footer>
</article>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="http://localhost:1313/">Tıp Notları</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu');
    if (menu) {
        
        const scrollPosition = localStorage.getItem("menu-scroll-position");
        if (scrollPosition) {
            menu.scrollLeft = parseInt(scrollPosition, 10);
        }
        
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        const html = document.querySelector("html");
        if (html.dataset.theme === "dark") {
            html.dataset.theme = 'light';
            localStorage.setItem("pref-theme", 'light');
        } else {
            html.dataset.theme = 'dark';
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
<script>
    document.querySelectorAll('pre > code').forEach((codeblock) => {
        const container = codeblock.parentNode.parentNode;

        const copybutton = document.createElement('button');
        copybutton.classList.add('copy-code');
        copybutton.innerHTML = 'copy';

        function copyingDone() {
            copybutton.innerHTML = 'copied!';
            setTimeout(() => {
                copybutton.innerHTML = 'copy';
            }, 2000);
        }

        copybutton.addEventListener('click', (cb) => {
            if ('clipboard' in navigator) {
                navigator.clipboard.writeText(codeblock.textContent);
                copyingDone();
                return;
            }

            const range = document.createRange();
            range.selectNodeContents(codeblock);
            const selection = window.getSelection();
            selection.removeAllRanges();
            selection.addRange(range);
            try {
                document.execCommand('copy');
                copyingDone();
            } catch (e) { };
            selection.removeRange(range);
        });

        if (container.classList.contains("highlight")) {
            container.appendChild(copybutton);
        } else if (container.parentNode.firstChild == container) {
            
        } else if (codeblock.parentNode.parentNode.parentNode.parentNode.parentNode.nodeName == "TABLE") {
            
            codeblock.parentNode.parentNode.parentNode.parentNode.parentNode.appendChild(copybutton);
        } else {
            
            codeblock.parentNode.appendChild(copybutton);
        }
    });
</script>
</body>

</html>
